Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Type 1 diabetes is associated with an increase in cholesterol absorption markers but a decrease in cholesterol synthesis markers in a young adult population.

Semova I, Levenson AE, Krawczyk J, Bullock K, Williams KA, Wadwa RP, Shah AS, Khoury PR, Kimball TR, Urbina EM, de Ferranti SD, Bishop FK, Maahs DM, Dolan LM, Clish CB, Biddinger SB.

J Clin Lipidol. 2019 Sep 25. pii: S1933-2874(19)30280-6. doi: 10.1016/j.jacl.2019.09.008. [Epub ahead of print]

PMID:
31706902
2.

The Use of Nonnutritive Sweeteners in Children.

Baker-Smith CM, de Ferranti SD, Cochran WJ; COMMITTEE ON NUTRITION, SECTION ON GASTROENTEROLOGY, HEPATOLOGY, AND NUTRITION.

Pediatrics. 2019 Nov;144(5). pii: e20192765. doi: 10.1542/peds.2019-2765.

PMID:
31659005
3.

Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.

Skulas-Ray AC, Wilson PWF, Harris WS, Brinton EA, Kris-Etherton PM, Richter CK, Jacobson TA, Engler MB, Miller M, Robinson JG, Blum CB, Rodriguez-Leyva D, de Ferranti SD, Welty FK; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology.

Circulation. 2019 Sep 17;140(12):e673-e691. doi: 10.1161/CIR.0000000000000709. Epub 2019 Aug 19.

PMID:
31422671
4.

Wearable Biosensors in Pediatric Cardiovascular Disease.

Tandon A, de Ferranti SD.

Circulation. 2019 Jul 30;140(5):350-352. doi: 10.1161/CIRCULATIONAHA.119.038483. Epub 2019 Jul 29. No abstract available.

PMID:
31356135
5.

Associations of Blood Pressure and Cholesterol Levels During Young Adulthood With Later Cardiovascular Events.

Zhang Y, Vittinghoff E, Pletcher MJ, Allen NB, Zeki Al Hazzouri A, Yaffe K, Balte PP, Alonso A, Newman AB, Ives DG, Rana JS, Lloyd-Jones D, Vasan RS, Bibbins-Domingo K, Gooding HC, de Ferranti SD, Oelsner EC, Moran AE.

J Am Coll Cardiol. 2019 Jul 23;74(3):330-341. doi: 10.1016/j.jacc.2019.03.529.

6.

Impact of Socioeconomic Status on Outcomes of Patients with Kawasaki Disease.

Dionne A, Bucholz EM, Gauvreau K, Gould P, Son MBF, Baker AL, de Ferranti SD, Fulton DR, Friedman KG, Newburger JW.

J Pediatr. 2019 Sep;212:87-92. doi: 10.1016/j.jpeds.2019.05.024. Epub 2019 Jun 20.

PMID:
31229318
7.

Trends in Levels of Lipids and Apolipoprotein B in US Youths Aged 6 to 19 Years, 1999-2016.

Perak AM, Ning H, Kit BK, de Ferranti SD, Van Horn LV, Wilkins JT, Lloyd-Jones DM.

JAMA. 2019 May 21;321(19):1895-1905. doi: 10.1001/jama.2019.4984.

8.

Is Echocardiography Critical in Patients With Kawasaki Disease With a Z-Score < 2 6 Weeks From Onset?-Reply.

de Ferranti SD, Newburger JW.

JAMA Pediatr. 2019 Jul 1;173(7):700-701. doi: 10.1001/jamapediatrics.2019.1222. No abstract available.

PMID:
31107519
9.

Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction.

Singh A, Gupta A, Collins BL, Qamar A, Monda KL, Biery D, Lopez JAG, de Ferranti SD, Plutzky J, Cannon CP, Januzzi JL Jr, Di Carli MF, Nasir K, Bhatt DL, Blankstein R.

J Am Coll Cardiol. 2019 May 21;73(19):2439-2450. doi: 10.1016/j.jacc.2019.02.059.

PMID:
31097165
10.

Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis.

Dionne A, Burns JC, Dahdah N, Tremoulet AH, Gauvreau K, de Ferranti SD, Baker AL, Son MB, Gould P, Fournier A, Newburger JW, Friedman KG.

Pediatrics. 2019 Jun;143(6). pii: e20183341. doi: 10.1542/peds.2018-3341. Epub 2019 May 2.

PMID:
31048414
11.

Impact of Treatment Modality on Vascular Function in Coarctation of the Aorta: The LOVE - COARCT Study.

Martins JD, Zachariah J, Selamet Tierney ES, Truong U, Morris SA, Kutty S, de Ferranti SD, Guarino M, Thomas B, Oliveira D, Marinho A, António M, Gauvreau K, Jalles N, Geva T, Carmo MM, Prakash A; LOVE‐COARCT Study.

J Am Heart Assoc. 2019 Apr 2;8(7):e011536. doi: 10.1161/JAHA.118.011536.

12.

Will Teens Go Red? Low Cardiovascular Disease Awareness Among Young Women.

Gooding HC, Brown CA, Liu J, Revette AC, Stamoulis C, de Ferranti SD.

J Am Heart Assoc. 2019 Mar 19;8(6):e011195. doi: 10.1161/JAHA.118.011195.

13.

Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association.

de Ferranti SD, Steinberger J, Ameduri R, Baker A, Gooding H, Kelly AS, Mietus-Snyder M, Mitsnefes MM, Peterson AL, St-Pierre J, Urbina EM, Zachariah JP, Zaidi AN.

Circulation. 2019 Mar 26;139(13):e603-e634. doi: 10.1161/CIR.0000000000000618.

PMID:
30798614
14.

Association of Maternal Prepregnancy Weight with Offspring Adiposity Throughout Adulthood over 37 Years of Follow-up.

Schoppa I, Lyass A, Heard-Costa N, de Ferranti SD, Fox C, Gillman MW, D'Agostino R Sr, Levy D, Mendelson MM.

Obesity (Silver Spring). 2019 Jan;27(1):137-144. doi: 10.1002/oby.22326. Epub 2018 Nov 25.

PMID:
30474203
15.

Experience participating in the American College of Cardiology Quality NetworkTM: paediatric and adult congenital cardiology collaborative quality improvement.

Hartwell LP, Baker AL, Jenkins KJ, de Ferranti SD, Saleeb SF.

Cardiol Young. 2019 Jan;29(1):59-66. doi: 10.1017/S104795111800183X. Epub 2018 Oct 30.

PMID:
30375299
16.

Hepatotoxicity of Statins as Determined by Serum Alanine Aminotransferase in a Pediatric Cohort With Dyslipidemia.

Desai NK, Mendelson MM, Baker A, Ryan HH, Griggs S, Boghani M, Yellen E, Buckley L, Gillman MW, Zachariah JP, Graham D, Jonas MM, de Ferranti SD.

J Pediatr Gastroenterol Nutr. 2019 Feb;68(2):175-181. doi: 10.1097/MPG.0000000000002174.

PMID:
30334928
17.

Association of Initially Normal Coronary Arteries With Normal Findings on Follow-up Echocardiography in Patients With Kawasaki Disease.

de Ferranti SD, Gauvreau K, Friedman KG, Tang A, Baker AL, Fulton DR, Tremoulet AH, Burns JC, Newburger JW.

JAMA Pediatr. 2018 Dec 1;172(12):e183310. doi: 10.1001/jamapediatrics.2018.3310. Epub 2018 Dec 3.

18.

Rationale and design of Long-term Outcomes and Vascular Evaluation after Successful Coarctation of the Aorta Treatment study.

Martins JD, Zachariah J, Selamet Tierney ES, Truong U, Morris SA, Kutty S, de Ferranti SD, Rhodes J, Antonio M, Guarino M, Thomas B, Oliveira D, Gauvreau K, Jalles N, Geva T, Carmo M, Prakash A.

Ann Pediatr Cardiol. 2018 Sep-Dec;11(3):282-296. doi: 10.4103/apc.APC_64_18.

19.

Diagnosis, Evaluation, and Management of High Blood Pressure in Children and Adolescents.

Baker-Smith CM, Flinn SK, Flynn JT, Kaelber DC, Blowey D, Carroll AE, Daniels SR, de Ferranti SD, Dionne JM, Falkner B, Gidding SS, Goodwin C, Leu MG, Powers ME, Rea C, Samuels J, Simasek M, Thaker VV, Urbina EM; SUBCOMMITTEE ON SCREENING AND MANAGEMENT OF HIGH BP IN CHILDREN.

Pediatrics. 2018 Sep;142(3). pii: e20182096. doi: 10.1542/peds.2018-2096. Epub 2018 Aug 20.

20.

Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel.

Sturm AC, Knowles JW, Gidding SS, Ahmad ZS, Ahmed CD, Ballantyne CM, Baum SJ, Bourbon M, Carrié A, Cuchel M, de Ferranti SD, Defesche JC, Freiberger T, Hershberger RE, Hovingh GK, Karayan L, Kastelein JJP, Kindt I, Lane SR, Leigh SE, Linton MF, Mata P, Neal WA, Nordestgaard BG, Santos RD, Harada-Shiba M, Sijbrands EJ, Stitziel NO, Yamashita S, Wilemon KA, Ledbetter DH, Rader DJ; Convened by the Familial Hypercholesterolemia Foundation.

J Am Coll Cardiol. 2018 Aug 7;72(6):662-680. doi: 10.1016/j.jacc.2018.05.044. Review.

21.

Squaring the Curve of Cardiovascular Health From the Beginning of Life.

Perak AM, Marino BS, de Ferranti SD.

Pediatrics. 2018 Apr;141(4). pii: e20172075. doi: 10.1542/peds.2017-2075. Review. No abstract available.

22.

Prevalence and Predictors of Cholesterol Screening, Awareness, and Statin Treatment Among US Adults With Familial Hypercholesterolemia or Other Forms of Severe Dyslipidemia (1999-2014).

Bucholz EM, Rodday AM, Kolor K, Khoury MJ, de Ferranti SD.

Circulation. 2018 May 22;137(21):2218-2230. doi: 10.1161/CIRCULATIONAHA.117.032321. Epub 2018 Mar 26.

23.

Obesity, Hypertension, and Dyslipidemia in Childhood Are Key Modifiable Antecedents of Adult Cardiovascular Disease: A Call to Action.

Turer CB, Brady TM, de Ferranti SD.

Circulation. 2018 Mar 20;137(12):1256-1259. doi: 10.1161/CIRCULATIONAHA.118.032531. No abstract available.

24.

Awareness of Cardiovascular Risk Factors in U.S. Young Adults Aged 18-39 Years.

Bucholz EM, Gooding HC, de Ferranti SD.

Am J Prev Med. 2018 Apr;54(4):e67-e77. doi: 10.1016/j.amepre.2018.01.022. Epub 2018 Feb 9.

25.

Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association.

Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, de Ferranti SD, Ferguson JF, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Lutsey PL, Mackey JS, Matchar DB, Matsushita K, Mussolino ME, Nasir K, O'Flaherty M, Palaniappan LP, Pandey A, Pandey DK, Reeves MJ, Ritchey MD, Rodriguez CJ, Roth GA, Rosamond WD, Sampson UKA, Satou GM, Shah SH, Spartano NL, Tirschwell DL, Tsao CW, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee.

Circulation. 2018 Mar 20;137(12):e67-e492. doi: 10.1161/CIR.0000000000000558. Epub 2018 Jan 31. Review. No abstract available. Erratum in: Circulation. 2018 Mar 20;137(12 ):e493.

PMID:
29386200
26.

Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents.

Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, de Ferranti SD, Dionne JM, Falkner B, Flinn SK, Gidding SS, Goodwin C, Leu MG, Powers ME, Rea C, Samuels J, Simasek M, Thaker VV, Urbina EM; SUBCOMMITTEE ON SCREENING AND MANAGEMENT OF HIGH BLOOD PRESSURE IN CHILDREN.

Pediatrics. 2017 Sep;140(3). pii: e20171904. doi: 10.1542/peds.2017-1904. Epub 2017 Aug 21. Erratum in: Pediatrics. 2017 Nov 30;:. Erratum in: Pediatrics. 2018 Sep;142(3):.

27.

USPSTF is unable to recommend for or against lipid screening to identify multifactorial dyslipidaemia in childhood: no recommendation is not without consequences.

de Ferranti SD, Sheldrick RC.

Evid Based Med. 2017 Oct;22(5):162-163. doi: 10.1136/ebmed-2016-110585. Epub 2017 Aug 17.

PMID:
28818963
28.

PCSK9 Is Increased in Youth With Type 1 Diabetes.

Levenson AE, Wadwa RP, Shah AS, Khoury PR, Kimball TR, Urbina EM, de Ferranti SD, Bishop FK, Maahs DM, Dolan LM, Biddinger SB.

Diabetes Care. 2017 Jul;40(7):e85-e87. doi: 10.2337/dc16-2563. Epub 2017 Jun 6. No abstract available.

29.

Safety and Efficacy of Warfarin Therapy in Kawasaki Disease.

Baker AL, Vanderpluym C, Gauvreau KA, Fulton DR, de Ferranti SD, Friedman KG, Murray JM, Brown LD, Almond CS, Evans-Langhorst M, Newburger JW.

J Pediatr. 2017 Oct;189:61-65. doi: 10.1016/j.jpeds.2017.04.051. Epub 2017 May 25.

PMID:
28552449
30.

Statin-Associated Myopathy in a Pediatric Preventive Cardiology Practice.

Johnson PK, Mendelson MM, Baker A, Ryan HH, Warren S, Graham D, Griggs SS, Desai NK, Yellen E, Buckley L, Zachariah JP, de Ferranti SD.

J Pediatr. 2017 Jun;185:94-98.e1. doi: 10.1016/j.jpeds.2017.02.047. Epub 2017 Mar 29.

31.

Calorically restricted diets decrease PCSK9 in overweight adolescents.

Levenson AE, Milliren CE, Biddinger SB, Ebbeling CB, Feldman HA, Ludwig DS, de Ferranti SD.

Nutr Metab Cardiovasc Dis. 2017 Apr;27(4):342-349. doi: 10.1016/j.numecd.2016.12.010. Epub 2017 Jan 3.

32.

Cholesterol Screening and Treatment Practices and Preferences: A Survey of United States Pediatricians.

de Ferranti SD, Rodday AM, Parsons SK, Cull WL, O'Connor KG, Daniels SR, Leslie LK.

J Pediatr. 2017 Jun;185:99-105.e2. doi: 10.1016/j.jpeds.2016.12.078. Epub 2017 Feb 13.

PMID:
28209292
33.

Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P; American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Circulation. 2017 Mar 7;135(10):e146-e603. doi: 10.1161/CIR.0000000000000485. Epub 2017 Jan 25. Review. No abstract available. Erratum in: Circulation. 2017 Mar 7;135(10 ):e646. Circulation. 2017 Sep 5;136(10 ):e196.

34.

Obesity and type 2 diabetes are associated with elevated PCSK9 levels in young women.

Levenson AE, Shah AS, Khoury PR, Kimball TR, Urbina EM, de Ferranti SD, Maahs DM, Dolan LM, Wadwa RP, Biddinger SB.

Pediatr Diabetes. 2017 Dec;18(8):755-760. doi: 10.1111/pedi.12490. Epub 2017 Jan 17.

35.

Familial Hypercholesterolemia.

Levenson AE, de Ferranti SD.

In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2016 Jun 22.

36.

Adolescent Dyslipidemia and Standardized Lifestyle Modification: Benchmarking Real-World Practice.

Zachariah JP, Chan J, Mendelson MM, Regh T, Griggs S, Johnson PK, Desai N, Gillman M, Graham D, de Ferranti SD.

J Am Coll Cardiol. 2016 Nov 8;68(19):2122-2123. doi: 10.1016/j.jacc.2016.08.041. No abstract available.

37.

Correlates of Achieving Statin Therapy Goals in Children and Adolescents with Dyslipidemia.

Mendelson MM, Regh T, Chan J, Baker A, Ryan HH, Palumbo N, Johnson PK, Griggs S, Boghani M, Desai NK, Yellen E, Buckley L, Gillman MW, Zachariah JP, Graham D, de Ferranti SD.

J Pediatr. 2016 Nov;178:149-155.e9. doi: 10.1016/j.jpeds.2016.08.003. Epub 2016 Aug 31.

38.

Cardiovascular Consequences of Childhood Secondhand Tobacco Smoke Exposure: Prevailing Evidence, Burden, and Racial and Socioeconomic Disparities: A Scientific Statement From the American Heart Association.

Raghuveer G, White DA, Hayman LL, Woo JG, Villafane J, Celermajer D, Ward KD, de Ferranti SD, Zachariah J; American Heart Association Committee on Atherosclerosis, Hypertension, and Obesity in the Young of the Council on Cardiovascular Disease in the Young; Behavior Change for Improving Health Factors Committee of the Council on Lifestyle and Cardiometabolic Health and Council on Epidemiology and Prevention; and Stroke Council.

Circulation. 2016 Oct 18;134(16):e336-e359. Epub 2016 Sep 12. Review. Erratum in: Circulation. 2016 Oct 18;134(16):e366.

39.

Nutrition in Children and Adolescents.

Corkins MR, Daniels SR, de Ferranti SD, Golden NH, Kim JH, Magge SN, Schwarzenberg SJ.

Med Clin North Am. 2016 Nov;100(6):1217-1235. doi: 10.1016/j.mcna.2016.06.005. Review.

PMID:
27745591
40.

Stakeholders' Perspectives on Stakeholder-engaged Research (SER): Strategies to Operationalize Patient-centered Outcomes Research Principles for SER.

Mackie TI, Sheldrick RC, de Ferranti SD, Saunders T, Rojas EG, Leslie LK.

Med Care. 2017 Jan;55(1):19-30.

PMID:
27547942
41.

Lipid Screening in Children and Adolescents.

Urbina EM, de Ferranti SD.

JAMA. 2016 Aug 9;316(6):589-91. doi: 10.1001/jama.2016.9671. No abstract available.

PMID:
27532913
42.

Young adult and parent stakeholder perspectives on participation in patient-centered comparative effectiveness research.

Saunders T, Mackie TI, Shah S, Gooding H, de Ferranti SD, Leslie LK.

J Comp Eff Res. 2016 Aug;5(5):487-97. doi: 10.2217/cer-2016-0025. Epub 2016 Jul 18.

PMID:
27427160
43.

Census tract based income level and lipid levels in urban pediatric primary care: a retrospective study.

Martinez EE, Forbes PW, O'Brien SE, de Ferranti SD.

BMC Pediatr. 2016 Jul 8;16:86. doi: 10.1186/s12887-016-0622-x.

44.

The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Nephrotic Syndrome-Associated Hypercholesterolemia.

Haas ME, Levenson AE, Sun X, Liao WH, Rutkowski JM, de Ferranti SD, Schumacher VA, Scherer PE, Salant DJ, Biddinger SB.

Circulation. 2016 Jul 5;134(1):61-72. doi: 10.1161/CIRCULATIONAHA.115.020912.

45.

Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype.

Perak AM, Ning H, de Ferranti SD, Gooding HC, Wilkins JT, Lloyd-Jones DM.

Circulation. 2016 Jul 5;134(1):9-19. doi: 10.1161/CIRCULATIONAHA.116.022335.

46.

Adolescent Perceptions of Cholesterol Screening Results: "Young Invincibles" or Developing Adults?

Gooding HC, Sheldrick RC, Leslie LK, Shah S, de Ferranti SD, Mackie TI.

J Adolesc Health. 2016 Aug;59(2):162-70. doi: 10.1016/j.jadohealth.2016.03.027. Epub 2016 May 5.

47.

Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES).

de Ferranti SD, Rodday AM, Mendelson MM, Wong JB, Leslie LK, Sheldrick RC.

Circulation. 2016 Mar 15;133(11):1067-72. doi: 10.1161/CIRCULATIONAHA.115.018791.

PMID:
26976914
48.

Effect of Leptin Replacement on PCSK9 in ob/ob Mice and Female Lipodystrophic Patients.

Levenson AE, Haas ME, Miao J, Brown RJ, de Ferranti SD, Muniyappa R, Biddinger SB.

Endocrinology. 2016 Apr;157(4):1421-9. doi: 10.1210/en.2015-1624. Epub 2016 Jan 29.

49.

Premature subclinical atherosclerosis in children and young adults with juvenile idiopathic arthritis. A review considering preventive measures.

Bohr AH, Fuhlbrigge RC, Pedersen FK, de Ferranti SD, Müller K.

Pediatr Rheumatol Online J. 2016 Jan 6;14(1):3. doi: 10.1186/s12969-015-0061-5. Review.

50.

Massachusetts Pediatricians' Views Toward Body Mass Index Screening in Schools: Continued Controversy.

Bottino CJ, de Ferranti SD, Meyers AF, Rhodes ET.

Clin Pediatr (Phila). 2016 Aug;55(9):844-50. doi: 10.1177/0009922815618487. Epub 2015 Dec 4.

PMID:
26637404

Supplemental Content

Loading ...
Support Center